|
The GERMELATOX DeCOG-trial: Attitude of German melanoma patients towards toxicity during adjuvant interferon treatment—Differences between the patient's and the physician's perspective. |
|
|
Honoraria - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Delcath Systems; GlaxoSmithKline; Medac; MSD; Roche Pharma AG |
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Delcath Systems; Galderma; GlaxoSmithKline; MSD; Roche Pharma AG |
|
Travel, Accommodations, Expenses - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Medac; MSD; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Research Funding - Janssen-Cilag |
Travel, Accommodations, Expenses - Janssen-Cilag |
|
|
No Relationships to Disclose |
|
|
Honoraria - Almirall Hermal GmbH; Amgen; Boston Biomedical; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG |
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer; Roche Pharma AG |
Research Funding - Johnson & Johnson; Novartis; Pfizer; Roche Pharma AG |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche Pharma AG |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG |
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG |
|
|
Consulting or Advisory Role - GlaxoSmithKline; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Roche Pharma AG |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche Pharma AG |
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD |
|
|
Honoraria - Almirall Hermal GmbH; Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Almirall Hermal GmbH; Merck Sharp & Dohme |
|
|
Honoraria - Bristol-Myers Squibb; Roche Pharma AG |
Consulting or Advisory Role - Boston Biomedical |
Speakers' Bureau - Amgen; Boston Biomedical; Bristol-Myers Squibb; Merck; Roche Pharma AG |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche Pharma AG |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche Pharma AG |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche Pharma AG |
|
|
Honoraria - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD |
|
|
Travel, Accommodations, Expenses - Aldavie; Galderma; La Roche-Posay; LEO Pharma; Pfizer |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG |
|
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
Honoraria - Bristol-Myers Squibb; Roche Pharma AG |
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG; Roche Pharma AG |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG |